clinical
-
Recon
AAOS Updates Clinical Practice Guideline for Surgical Management of Osteoarthritis of the Knees
Updated guideline offers the latest in evidence-based research to improve surgical success and reduce complications and postoperative pain ROSEMONT, Ill., Jan.…
Read More » -
Sports Medicine
AAOS Updates Clinical Practice Guideline for Management of Anterior Cruciate Ligament Injuries
Updated guideline offers the latest in evidence-based recommendations including considerations for skeletal maturity and activity level in patients with ACL…
Read More » -
Spine
Aurora Spine Corporation Announces Newly Published Paper on Need for a Bone Mineral Density-Matched Interbody Cage
CARLSBAD, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),…
Read More » -
COVID-19
Hospitals paying $24 billion more for labor during the COVID-19 pandemic
Clinical labor costs are up by an average of 8% per patient day, translating to $17 million in additional annual…
Read More » -
Recon
Clinical Pilot Study Confirms the Accuracy and Effectiveness of Pixee Medical’s Knee+ Solution Using Vuzix M400 Smart Glasses for Total Knee Arthroplasty
– Vuzix receives follow-on M400 Smart Glasses order from Pixee Medical ROCHESTER, N.Y., Sept. 17, 2021 /PRNewswire/ — Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the…
Read More » -
Biologics
Ortho Regenerative Technologies Announces the Nomination of its New Vice-president Clinical and Medical Affairs
MONTREAL, Oct. 19, 2020 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTI” or the “Company“), an emerging orthobiologics company focused on…
Read More » -
Biologics
BBS-Bioactive Bone Substitutes Plc: We are pleased to announce that the clinical result of ARTEBONE® is positive yielding an outcome similar to patient’s own bone graft
19.2.2020 The clinical investigation run by BBS-Bioactive Bone Substitutes Oyj in clinical centers in Finland and Poland has been finalized…
Read More » -
Financial
Embody, Inc. Extends DARPA Funding to $14.35 Million
NORFOLK, Va., Jan. 14, 2020 /PRNewswire/ —Embody, Inc., a privately-held medical device company focused on soft tissue repair, announced today they have…
Read More » -
Spine
First Clinical Publication in Japan for the SpineGuard DSG® Technology
December 16, 2019 PARIS & BOULDER, Colo.–(BUSINESS WIRE)–Regulatory News: SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative company that deploys its DSG®…
Read More » -
Biologics
Anika Appoints Mira Leiwant as Vice President of Regulatory Affairs, Quality, and Clinical Affairs
October 14, 2019 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated company, focused on developing regenerative therapies leveraging its…
Read More » -
Biologics
Early data demonstrate motor function improvement for spinal cord stem cell treatment
26th January 2017 A new therapy to treat spinal cord injuries in people who have lost all motor and sensory…
Read More »